MedPath

Trigeminal Evoked Responses to Improve Rhizotomy

Early Phase 1
Recruiting
Conditions
Trigeminal Neuralgia
Rhizotomy
Interventions
Other: TSEP + rhizotomy surgery
Other: TSEPs recording only
Registration Number
NCT05738096
Lead Sponsor
University of Minnesota
Brief Summary

Trigeminal neuralgia (TGN) is a debilitating pain syndrome where electrical, shock- like jolts of pain affect the face. Trigeminal somatosensory evoked potentials (TSEPs) provide a promising modality for measuring the trigeminal sensory and nociceptive pathway by using peripheral stimulation of the trigeminal nerve (on the skin) and measuring low latency evoked potentials on the scalp (contralateral sensory cortex). While TSEPs have been measured in the past, it is not clear if implementing TSEPs into a routine neurosurgical rhizotomy procedure will be feasible. This is a prospective cohort study examining the feasibility of routinely performing TSEPs during rhizotomies for TGN.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adults of 18 years or older
  • Scheduled to undergo percutaneous rhizotomy for facial pain
Exclusion Criteria
  • For TGN: Facial pain of unclear origin (i.e. not clearly TGN pain) or Rhizotomy procedure canceled
  • For Healthy control: Diagnosis or history of facial pain such as TMD or TGN, History of migraine, History of any functional pain disorder: fibromyalgia, IBS, CRPS or Recent chronic pain (within last month)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TGN patientsTSEP + rhizotomy surgeryPatients with TGN who will undergo rhizotomy surgery as the standard of care
Healthy volunteersTSEPs recording onlyHealthy volunteers for whom TSEPS will be recorded in a lab setting
Primary Outcome Measures
NameTimeMethod
Feasibility3 years

total study procedure completion rate

Secondary Outcome Measures
NameTimeMethod
TSEPS latency between control and TGN patients1 day

difference in latency between healthy participants and TGN patients

TSEPS peak to peak amplitude within TGN1 day

difference in measured peak to peak amplitude between normal and TGN side

TSEPS latency within TGN1 day

difference in measured TSEPS latency between normal and TGN side

TSEPS peak to peak amplitude between control and TGN patients1 day

difference in measured peak to peak amplitude between healthy participants and TGN patients

Trial Locations

Locations (1)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath